Your browser doesn't support javascript.
loading
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension study.
Mei, Heng; Liu, Xiaofan; Li, Yan; Zhou, Hu; Feng, Ying; Gao, Guangxun; Cheng, Peng; Huang, Ruibin; Yang, Linhua; Hu, Jianda; Hou, Ming; Yao, Yazhou; Liu, Li; Wang, Yi; Wu, Depei; Zhang, Liansheng; Zheng, Changcheng; Shen, Xuliang; Hu, Qi; Liu, Jing; Jin, Jie; Luo, Jianmin; Zeng, Yun; Gao, Sujun; Zhang, Xiaohui; Zhou, Xin; Shi, Qingzhi; Xia, Ruixiang; Xie, Xiaobao; Jiang, Zhongxing; Gao, Li; Bai, Yuansong; Li, Yan; Xiong, Junye; Li, Runzi; Zou, Jianjun; Niu, Ting; Yang, Renchi; Hu, Yu.
Afiliación
  • Mei H; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu X; Thrombosis and Hemostasis Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Tianjin Laboratory of Blood Disease Gene Therapy, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospi
  • Li Y; Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Zhou H; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Feng Y; Department of Hematopathology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Gao G; The Blood Internal Medicine, The First Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Cheng P; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Huang R; Hematology Department, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yang L; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Hu J; Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Hou M; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Yao Y; Hematology Department, Baoji Central Hospital, Baoji, China.
  • Liu L; Department of Hematopathology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Wang Y; Department of Hematopathology, Shaanxi Provincial People's Hospital, Xi'an, China.
  • Wu D; Hematology Department, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang L; Hematology Department, Lanzhou University Second Hospital, Lanzhou, China.
  • Zheng C; Hematology Department, The First Affiliated Hospital of USTC, Hefei, China.
  • Shen X; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
  • Hu Q; Department of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China.
  • Liu J; Hematology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Jin J; Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
  • Luo J; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zeng Y; Department of Hematology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Gao S; Hematology, The First Hospital of Jilin University, Changchun, China.
  • Zhang X; Department of Hematology, Peking University People's Hospital, Beijing, China.
  • Zhou X; Hematology Department, Wuxi People's Hospital, Wuxi, China.
  • Shi Q; Hematology Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Xia R; Hematology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xie X; Hematology Department, The First People's Hospital of Changzhou, Changzhou, China.
  • Jiang Z; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Gao L; Department of Hematology, The Second Affiliated Hospital of Military Medical University PLA, Chongqing, China.
  • Bai Y; Hematology & Oncology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Li Y; Hematology Department, The First Hospital of China Medical University, Shenyang, China.
  • Xiong J; Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Li R; Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Zou J; Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Niu T; Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Yang R; Thrombosis and Hemostasis Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Tianjin Laboratory of Blood Disease Gene Therapy, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospi
  • Hu Y; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
J Thromb Haemost ; 20(3): 716-728, 2022 03.
Article en En | MEDLINE | ID: mdl-34821020
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trombocitopenia / Púrpura Trombocitopénica Idiopática / Pirazolonas Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trombocitopenia / Púrpura Trombocitopénica Idiopática / Pirazolonas Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article